New french tool aims to measure how hyperparathyroidism affects daily life
NCT ID NCT06450431
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to validate a French version of the Parathyroid Assessment of Symptoms (PAS) questionnaire for people with primary hyperparathyroidism. Researchers will ask 548 patients to fill out the PAS.fr and a standard quality-of-life questionnaire before and after surgery. The goal is to ensure the tool accurately measures how the condition and its treatment impact quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a reliable French-language tool to measure how primary hyperparathyroidism affects quality of life and how surgery may help.
- What could go wrong
- This is an observational validation study, not a treatment trial. It does not test a new therapy, so it will not directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for QUALITY OF LIFE IN PRIMARY HYPERPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nantes University Hospital
RECRUITINGNantes, Loire-Atlantique, 44093, France